Dr. Reddy's Laboratories Limited RDY
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 861.19M | 936.52M | 919.12M | 785.88M | 777.57M |
| Total Receivables | 1.07B | 1.08B | 1.16B | 1.13B | 1.14B |
| Inventory | 851.10M | 816.19M | 879.28M | 853.53M | 881.48M |
| Prepaid Expenses | 27.41M | 22.13M | 22.87M | 25.68M | 23.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 355.91M | 361.45M | 330.77M | 349.43M | 320.24M |
| Total Current Assets | 3.17B | 3.22B | 3.31B | 3.15B | 3.15B |
|
|
|||||
| Total Current Assets | 3.17B | 3.22B | 3.31B | 3.15B | 3.15B |
| Net Property, Plant & Equipment | 1.22B | 1.24B | 1.29B | 1.26B | 1.20B |
| Long-term Investments | 136.01M | 137.50M | 138.11M | 138.44M | 139.63M |
| Goodwill | 136.01M | 137.50M | 138.11M | 138.44M | 139.63M |
| Total Other Intangibles | 1.10B | 1.12B | 1.14B | 1.14B | 1.11B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 297.01M | 289.24M | 279.66M | 309.59M | 324.89M |
| Total Assets | 6.08B | 6.18B | 6.26B | 6.10B | 6.06B |
|
|
|||||
| Total Accounts Payable | 396.58M | 238.49M | 454.01M | 453.08M | 436.74M |
| Total Accrued Expenses | 387.61M | 506.17M | 424.69M | 436.50M | 404.27M |
| Short-term Debt | 610.12M | 630.66M | 559.62M | 463.29M | 447.51M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.17M | 64.02M | 64.97M | 64.69M | 60.25M |
| Total Finance Division Other Current Liabilities | 244.60M | 347.71M | 258.51M | 281.45M | 313.81M |
| Total Other Current Liabilities | 244.60M | 347.71M | 258.51M | 281.45M | 313.81M |
| Total Current Liabilities | 1.66B | 1.79B | 1.76B | 1.70B | 1.66B |
|
|
|||||
| Total Current Liabilities | 1.66B | 1.79B | 1.76B | 1.70B | 1.66B |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 610.12M | 630.66M | 559.62M | 463.29M | 447.51M |
| Capital Leases | 125.69M | 130.14M | 129.18M | 131.00M | 59.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 204.60M | 203.91M | 191.69M | 195.41M | 210.98M |
| Total Liabilities | 1.99B | 2.12B | 2.08B | 2.03B | 1.93B |
|
|
|||||
| Common Stock & APIC | 130.02M | 130.10M | 135.39M | 136.72M | 141.16M |
| Retained Earnings | 3.77B | 3.75B | 3.89B | 3.80B | 3.85B |
| Treasury Stock & Other | 155.63M | 137.36M | 115.93M | 97.50M | 93.06M |
| Total Common Equity | 4.06B | 4.02B | 4.14B | 4.04B | 4.08B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.06B | 4.02B | 4.14B | 4.04B | 4.08B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 34.98M | 36.20M | 37.73M | 40.45M | 43.09M |
| Total Equity | 4.09B | 4.06B | 4.18B | 4.08B | 4.12B |
|
|
|||||